Skip to main content

Histopathological Assessment of Patient-Derived Xenografts

BRD ID: 2274
Tier: SOP
Source: PDMR
Document: SOP50103_Histopath_Review_PDXs.pdf[Size: 220.32 KB]
Number of times downloaded: 675

Description

This document describes the procedures used by the Molecular Characterization and Clinical Assay Development Laboratory (MoCha) for histopathological review of hematoxylin & eosin-stained sections of patient-derived xenografts used by a board-certified pathologist at NCI-Frederick, Frederick National Laboratory for Cancer Research. It is a product of the National Cancer Institute's (NCI) Patient-Derived Models Repository (PDMR; https://dctd.cancer.gov/drug-discovery-development/reagents-materials/pdmr) and is available at https://dctd.cancer.gov/drug-discovery-development/reagents-materials/pdmr/using-pdmr/sops.